Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Stephan Huveneers, Hoa Truong & Erik H. J. Danen. (2007) Integrins: Signaling, disease, and therapy. International Journal of Radiation Biology 83:11-12, pages 743-751.
Read now
Read now
T. Prueksaritanont, C. Fernandez-Metzler, Y. Meng, A. Barrish, W. Halczenko, S. B. Rodan, J. H. Hutchinson, M. E. Duggan & J. H. Lin. (2004) Disposition of a novel and potent αvβ3 antagonist in animals, and extrapolation to man. Xenobiotica 34:1, pages 103-115.
Read now
Read now
T. Prueksaritanont, J. H. Hochman, Y. Meng, N. T. Pudvah, A. Barrish, B. Ma, M. Yamazaki, C. Fernandez-metzler & J. H. Lin. (2004) Renal elimination of a novel and potent αvβ3 integrin antagonist in animals. Xenobiotica 34:11-12, pages 1059-1074.
Read now
Read now
T. Prueksaritanont, X. Xu, P. Deluna, M. Yamazaki & J. H. Lin. (2003) Stereoselective hepatic disposition of a diastereomeric pair of αvβ3 antagonists in rat. Xenobiotica 33:11, pages 1125-1137.
Read now
Read now
Diane M Biskobing. (2003) Novel therapies for osteoporosis. Expert Opinion on Investigational Drugs 12:4, pages 611-621.
Read now
Read now
Larry W Moreland & Richard J Misischia. (2002) Rheumatoid arthritis: developing pharmacological therapies. Expert Opinion on Investigational Drugs 11:7, pages 927-935.
Read now
Read now
Thomas R Gadek & Denise A Ockey. (2002) Inhibitors of protein-protein interactions. Expert Opinion on Therapeutic Patents 12:3, pages 393-400.
Read now
Read now
T. Prueksaritanont, Y. Meng, B. Ma, P. Leppert, J. Hochman, C. Tang, J. Perkins, M. Zrada, R. Meissner, M.E Duggan & J.H Lin. (2002) Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of α v β 3 - antagonists in rat: limited role of P-glycoprotein. Xenobiotica 32:3, pages 207-220.
Read now
Read now
Mark E Duggan & John H Hutchinson. (2000) Ligands to the integrin receptor αvβ3. Expert Opinion on Therapeutic Patents 10:9, pages 1367-1383.
Read now
Read now
Articles from other publishers (44)
Fangyi chen, Jiao Liu, Ting Yang, Jianwei Sun, Xianwei He, Xinjie Fu, Shigang Qiao, Jianzhong An & Jiao Yang. (2023) Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data. Journal of Bone Oncology 41, pages 100493.
Crossref
Crossref
Zhiguang Chen, Haibin Zhao, Lingshuai Meng, Shengwei Yu, Zhenning Liu & Jinqi Xue. (2023) Microfibril-Associated Glycoprotein-2 Promoted Fracture Healing via Integrin αvβ3/PTK2/AKT Signaling. Laboratory Investigation 103:7, pages 100121.
Crossref
Crossref
Hao Xu, Wentao Wang, Xin Liu, Wei Huang, Chen Zhu, Yaozeng Xu, Huilin Yang, Jiaxiang Bai & Dechun Geng. (2023) Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Siripat Chaichit, Pathomwat Wongrattanakamon, Busaban Sirithunyalug, Piyarat Nimmanpipug & Supat Jiranusornkul. (2022) Multitarget-Based Virtual Screening for Identification of Herbal Substances toward Potential Osteoclastic Targets. Applied Sciences 12:5, pages 2621.
Crossref
Crossref
R. Lindenwald, H. Pendl, H. Scholtes, H.-J. Schuberth & S. Rautenschlein. (2019) Flow-cytometric analysis of circulating leukocyte populations in turkeys: Establishment of a whole blood analysis approach and investigations on possible influencing factors. Veterinary Immunology and Immunopathology 210, pages 46-54.
Crossref
Crossref
Harshika Awasthi, Dayanandan Mani, Divya Singh & Atul Gupta. (2018) The underlying pathophysiology and therapeutic approaches for osteoporosis. Medicinal Research Reviews 38:6, pages 2024-2057.
Crossref
Crossref
Ramesh N. Patel. (2018) Biocatalysis for synthesis of pharmaceuticals. Bioorganic & Medicinal Chemistry 26:7, pages 1252-1274.
Crossref
Crossref
Richard J. D. Hatley, Simon J. F. Macdonald, Robert J. Slack, Joelle Le, Steven B. Ludbrook & Pauline T. Lukey. (2018) An αv‐RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities. Angewandte Chemie International Edition 57:13, pages 3298-3321.
Crossref
Crossref
Richard J. D. Hatley, Simon J. F. Macdonald, Robert J. Slack, Joelle Le, Steven B. Ludbrook & Pauline T. Lukey. (2018) Ein Instrumentarium von αv-RGD-Integrin-Inhibitoren: Wirkstoffsuche, Herausforderungen und Möglichkeiten. Angewandte Chemie 130:13, pages 3354-3379.
Crossref
Crossref
Tao Ma, Kavitha Sadashivaiah & Meenakshi A. Chellaiah. (2010) Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts. Journal of Biological Chemistry 285:39, pages 29911-29924.
Crossref
Crossref
Miep H. Helfrich, Gudrun Stenbeck, Stephen A. Nesbitt & Michael A. Horton. 2008. Principles of Bone Biology. Principles of Bone Biology
385
424
.
Yingshe Zhao, Richard Bachelier, Isabelle Treilleux, Philippe Pujuguet, Olivier Peyruchaud, Roland Baron, Philippe Clément-Lacroix & Philippe Clézardin. (2007) Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases. Cancer Research 67:12, pages 5821-5830.
Crossref
Crossref
Srinivasan R. Nagarajan, Hwang-Fun Lu, Alan F. Gasiecki, Ish K. Khanna, Mihir D. Parikh, Bipinchandra N. Desai, Thomas E. Rogers, Michael Clare, Barbara B. Chen, Mark A. Russell, Jeffery L. Keene, Tiffany Duffin, V. Wayne Engleman, Mary B. Finn, Sandra K. Freeman, Jon A. Klover, G. Alan Nickols, Maureen A. Nickols, Kristen E. Shannon, Christina A. Steininger, William F. Westlin, Marisa M. Westlin & Melanie L. Williams. (2007) Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective αvβ3 inhibitor: Design, synthesis, and optimization. Bioorganic & Medicinal Chemistry 15:10, pages 3390-3412.
Crossref
Crossref
Luca Gentilucci, Giuliana Cardillo, Federico Squassabia, Alessandra Tolomelli, Santi Spampinato, Antonino Sparta & Monica Baiula. (2007) Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. Bioorganic & Medicinal Chemistry Letters 17:8, pages 2329-2333.
Crossref
Crossref
Pierre Raboisson, Renee L. DesJarlais, Rolanda Reed, Jennifer Lattanze, Margery Chaikin, Carl L. Manthey, Bruce E. Tomczuk & Juan José Marugán. (2007) Identification of novel short chain 4-substituted indoles as potent αvβ3 antagonist using structure-based drug design. European Journal of Medicinal Chemistry 42:3, pages 334-343.
Crossref
Crossref
Mikhail Popkov, Christoph Rader, Beatriz Gonzalez, Subhash C. Sinha & Carlos F. Barbas. (2006) Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector. International Journal of Cancer 119:5, pages 1194-1207.
Crossref
Crossref
Pierre Raboisson, Carl L. Manthey, Margery Chaikin, Jennifer Lattanze, Carl Crysler, Kristi Leonard, Wenxi Pan, Bruce E. Tomczuk & Juan José Marugán. (2006) Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin. European Journal of Medicinal Chemistry 41:7, pages 847-861.
Crossref
Crossref
Thomas D. Penning, Albert Khilevich, Barbara B. Chen, Mark A. Russell, Mark L. Boys, Yaping Wang, Tiffany Duffin, V. Wayne Engleman, Mary Beth Finn, Sandra K. Freeman, Melanie L. Hanneke, Jeffery L. Keene, Jon A. Klover, G. Allen Nickols, Maureen A. Nickols, Randall K. Rader, Steven L. Settle, Kristen E. Shannon, Christina N. Steininger, Marisa M. Westlin & William F. Westlin. (2006) Synthesis of pyrazoles and isoxazoles as potent αvβ3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 16:12, pages 3156-3161.
Crossref
Crossref
Srinivasan R. Nagarajan, Jane M. Meyer, Julie M. Miyashiro, V. Wayne Engleman, Sandra K. Freeman, David W. Griggs, Jon A. Klover & G. Alan Nickols. (2006) Discovery of Diphenylmethanepropionic and Dihydrostilbeneacetic Acids as Antagonists of the Integrin alphavbeta3. Chemical Biology <html_ent glyph="@amp;" ascii="&"/> Drug Design 67:2, pages 177-181.
Crossref
Crossref
John A. Wendt, Hongwei Wu, Heather G. Stenmark, Mark L. Boys, Victoria L. Downs, Thomas D. Penning, Barbara B. Chen, Yaping Wang, Tiffany Duffin, Mary Beth Finn, Jeffery L. Keene, V. Wayne Engleman, Sandra K. Freeman, Melanie L. Hanneke, Kristen E. Shannon, Maureen A. Nickols, Christina N. Steininger, Marissa Westlin, Jon A. Klover, William Westlin, G. Allen Nickols & Mark A. Russell. (2006) Synthesis of 2,5-thiazole butanoic acids as potent and selective ?v?3 integrin receptor antagonists with improved oral pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters 16:4, pages 845-849.
Crossref
Crossref
Mark L. Boys, Lori A. Schretzman, Nizal S. Chandrakumar, Michael B. Tollefson, Scott B. Mohler, Victoria L. Downs, Thomas D. Penning, Mark A. Russell, John A. Wendt, Barbara B. Chen, Heather G. Stenmark, Hongwei Wu, Dale P. Spangler, Michael Clare, Bipin N. Desai, Ish K. Khanna, Maria N. Nguyen, Tiffany Duffin, V. Wayne Engleman, Mary Beth Finn, Sandra K. Freeman, Melanie L. Hanneke, Jeffery L. Keene, Jon A. Klover, G. Allen Nickols, Maureen A. Nickols, Christina N. Steininger, Marisa Westlin, William Westlin, Yi X. Yu, Yaping Wang, Christopher R. Dalton & Sarah A. Norring. (2006) Convergent, parallel synthesis of a series of ?-substituted 1,2,4-oxadiazole butanoic acids as potent and selective ?v?3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 16:4, pages 839-844.
Crossref
Crossref
Julie Rice, Donald L. Courter, Cecilia M. Giachelli & Marta Scatena. (2006) Molecular Mediators of α<sub>v</sub>β<sub>3</sub>-Induced Endothelial Cell Survival. Journal of Vascular Research 43:5, pages 422-436.
Crossref
Crossref
Amy E. Zartman, Le T. Duong, Carmen Fernandez-Metzler, George D. Hartman, Chih-Tai Leu, Thomayant Prueksaritanont, Gideon A. Rodan, Sevgi B. Rodan, Mark E. Duggan & Robert S. Meissner. (2005) Nonpeptide αvβ3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimetics. Bioorganic & Medicinal Chemistry Letters 15:6, pages 1647-1650.
Crossref
Crossref
Michael J Breslin, Mark E Duggan, Wasyl Halczenko, George D Hartman, Le T Duong, Carmen Fernandez-Metzler, Michael A Gentile, Donald B Kimmel, Chih-Tai Leu, Kara Merkle, Thomayant Prueksaritanont, Gideon A Rodan, Sevgi B Rodan & John H Hutchinson. (2004) Nonpeptide αvβ3 antagonists. Part 10: In vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivative. Bioorganic & Medicinal Chemistry Letters 14:17, pages 4515-4518.
Crossref
Crossref
Donghui Cui, Raju Subramanian, Magang Shou, Xiao Yu, Michael A. Wallace, Matthew P. Braun, Byron H. Arison, James A. Yergey & Thomayant Prueksaritanont. (2004)
IN VITRO AND IN VIVO METABOLISM OF A POTENT AND SELECTIVE INTEGRIN α
v
β
3
ANTAGONIST IN RATS, DOGS, AND MONKEYS
. Drug Metabolism and Disposition 32:8, pages 848-861.
Crossref
Crossref
Thomas D. Penning, Mark A. Russell, Barbara B. Chen, Helen Y. Chen, Bipin N. Desai, Stephen H. Docter, David J. Edwards, Glen J. Gesicki, Chi-Dean Liang, James W. Malecha, Stella S. Yu, V.Wayne Engleman, Sandra K. Freeman, Melanie L. Hanneke, Kristen E. Shannon, Marisa M. Westlin & G.Allen Nickols. (2004) Synthesis of cinnamic acids and related isosteres as potent and selective ?v?3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 14:6, pages 1471-1476.
Crossref
Crossref
Paola Vianello, Paolo Cozzi, Arturo Galvani, Maurizio Meroni, Mario Varasi, Daniele Volpi & Tiziano Bandiera. (2004) Solid-phase synthesis of a small library of 3-phenylthio-3-nicotinyl propionic acid derivatives acting as antagonists of the integrin αVβ3. Bioorganic & Medicinal Chemistry Letters 14:3, pages 657-661.
Crossref
Crossref
Jiabing Wang, Michael J. Breslin, Paul J. Coleman, Mark E. Duggan, Cecilia A. Hunt, John H. Hutchinson, Chih-Tai Leu, Sevgi B. Rodan, Gideon A. Rodan, Le T. Duong & George D. Hartman. (2004) Non-peptide α v β 3 antagonists. Part 7: 3-Substituted tetrahydro- [1,8] naphthyridine derivatives. Bioorganic & Medicinal Chemistry Letters 14:4, pages 1049-1052.
Crossref
Crossref
George D. Hartman & Robert S. Meissner. 2004.
67
78
.
James J Perkins, L.T Duong, Carmen Fernandez-Metzler, George D Hartman, Donald B Kimmel, Chih-Tai Leu, Joseph J Lynch, Thomayant Prueksaritanont, Gideon A Rodan, Sevgi B Rodan, Mark E Duggan & Robert S Meissner. (2003) Non-peptide α v β 3 antagonists: Identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint. Bioorganic & Medicinal Chemistry Letters 13:24, pages 4285-4288.
Crossref
Crossref
Manuela Bezzi, Meriem Hasmim, Grégory Bieler, Olivier Dormond & Curzio Rüegg. (2003) Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell Death. Journal of Biological Chemistry 278:44, pages 43603-43614.
Crossref
Crossref
John H. Hutchinson, Wasyl Halczenko, Karen M. Brashear, Michael J. Breslin, Paul J. Coleman, Le T. Duong, Carmen Fernandez-Metzler, Michael A. Gentile, John E. Fisher, George D. Hartman, Joel R. Huff, Donald B. Kimmel, Chih-Tai Leu, Robert S. Meissner, Kara Merkle, Rose Nagy, Brenda Pennypacker, James J. Perkins, Thomayant Prueksaritanont, Gideon A. Rodan, Sandor L. Varga, Greg A. Wesolowski, Amy E. Zartman, Sevgi B. Rodan & Mark E. Duggan. (2003)
Nonpeptide α
v
β
3
Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent α
v
β
3
Antagonist for the Prevention and Treatment of Osteoporosis
. Journal of Medicinal Chemistry 46:22, pages 4790-4798.
Crossref
Crossref
Michael A. Horton, Helen M. Massey, Nurit Rosenberg, Brian Nicholls, Uri Seligsohn & Adrienne M. Flanagan. (2003) Upregulation of osteoclast α2β1 integrin compensates for lack of αvβ3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. British Journal of Haematology 122:6, pages 950-957.
Crossref
Crossref
Michael J Breslin, Mark E Duggan, Wasyl Halczenko, Carmen Fernandez-Metzler, Cecilia A Hunt, Chih-Tai Leu, Kara M Merkle, Adel M Naylor-Olsen, Thomayant Prueksaritanont, Gary Stump, Audrey Wallace, Sevgi B Rodan & John H Hutchinson. (2003) Non-Peptide αvβ3 antagonists. Part 6: Design and synthesis of αvβ3 antagonists containing a pyridone or pyrazinone central scaffold. Bioorganic & Medicinal Chemistry Letters 13:10, pages 1809-1812.
Crossref
Crossref
William H Miller, Peter J Manley, Russell D Cousins, Karl F Erhard, Dirk A Heerding, Chet Kwon, Stephen T Ross, James M Samanen, Dennis T Takata, Irene N Uzinskas, Catherine C.K Yuan, R.Curtis Haltiwanger, Catherine J Gress, Michael W Lark, Shing-Mei Hwang, Ian E James, David J Rieman, Robert N Willette, Tian-Li Yue, Leonard M Azzarano, Kevin L Salyers, Brian R Smith, Keith W Ward, Kyung O Johanson & William F Huffman. (2003) Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists. Bioorganic & Medicinal Chemistry Letters 13:8, pages 1483-1486.
Crossref
Crossref
Karen Meerovitch, Fr?d?ric Bergeron, Lorraine Leblond, Brigitte Grouix, Cathy Poirier, Monica Bubenik, Laval Chan, Henriette Gourdeau, Terry Bowlin & Giorgio Attardo. (2003) A novel RGD antagonist that targets both ?v?3 and ?5?1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascular Pharmacology 40:2, pages 77-89.
Crossref
Crossref
Monica Bubenik, Karen Meerovitch, Frédéric Bergeron, Giorgio Attardo & Laval Chan. (2003) Thiophene-based vitronectin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 13:3, pages 503-506.
Crossref
Crossref
Françoise Perron-Sierra, Dominique Saint Dizier, Marc Bertrand, Annie Genton, Gordon C Tucker & Patrick Casara. (2002) Substituted benzocyloheptenes as potent and selective αv integrin antagonists. Bioorganic & Medicinal Chemistry Letters 12:22, pages 3291-3296.
Crossref
Crossref
Paul J. Coleman, Ben C. Askew, John H. Hutchinson, David B. Whitman, James J. Perkins, George D. Hartman, Gideon A. Rodan, Chih-Tai Leu, Thomayant Prueksaritanont, Carmen Fernandez-Metzler, Kara M. Merkle, Robert Lynch, Joseph J. Lynch, Sevgi B. Rodan & Mark E. Duggan. (2002) Non-Peptide αvβ3 Antagonists. Part 4: Potent and Orally Bioavailable Chain-Shortened RGD Mimetics. Bioorganic & Medicinal Chemistry Letters 12:17, pages 2463-2465.
Crossref
Crossref
Paul J Hippenmeyer, Peter G Ruminski, Joseph G Rico, H.S.Sharon Lu & David W Griggs. (2002) Adenovirus inhibition by peptidomimetic integrin antagonists. Antiviral Research 55:1, pages 169-178.
Crossref
Crossref
Andreas Kling, Gisela Backfisch, Jürgen Delzer, Hervé Geneste, Claudia Graef, Uta Holzenkamp, Wilfried Hornberger, Udo E.W Lange, Arnulf Lauterbach, Helmut Mack, Werner Seitz & Thomas Subkowski. (2002) Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective αVβ3 antagonists. Bioorganic & Medicinal Chemistry Letters 12:3, pages 441-446.
Crossref
Crossref
Michael A. Horton, Stephen A. Nesbitt, Jon H. Bennett & Gudrun Stenbeck. 2002. Principles of Bone Biology. Principles of Bone Biology
265
XX
.
Le T. Duong, Archana Sanjay, William Horne, Roland Baron & Gideon A. Rodan. 2002. Principles of Bone Biology. Principles of Bone Biology
141
VII
.
Anusch Peyman, Karl-Heinz Scheunemann, David W. Will, Jochen Knolle, Volkmar Wehner, Gerhard Breipohl, Hans Ulrich Stilz, Denis Carniato, Jean-Marie Ruxer, Jean-Francois Gourvest, Marielle Auberval, Bernard Doucet, Roland Baron, Martine Gaillard, Thomas R. Gadek & Sarah Bodary. (2001) αvβ3 Antagonists Based on a Central Thiophene Scaffold. Bioorganic & Medicinal Chemistry Letters 11:15, pages 2011-2015.
Crossref
Crossref